Barclays initiates Edwards Lifesciences at Overweight
Barclays initiated coverage of Edwards Lifesciences with an Overweight rating, per Benzinga’s reported ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Barclays initiates Edwards Lifesciences at Overweight, $110 target
Barclays initiated Edwards Lifesciences with an Overweight rating and a $110.00 per-share price target.